US2013203160A1PendingUtilityA1

Transgenomic Mitochondria, Transmitochondrial Cells and Organisms, and Methods of Making and Using

Individually held — no corporate assignee on recordPriority: Apr 15, 2004Filed: Apr 8, 2013Published: Aug 8, 2013
Est. expiryApr 15, 2024(expired)· nominal 20-yr term from priority
C12N 15/1027C12N 15/87C12N 15/8509C12N 2800/90C12N 1/16C12N 15/63C12N 15/81
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention provides transgenomic mitochondria, transmitochondrial cells and organisms, and the materials and methods for making such mitochondria, cells and organisms.

Claims

exact text as granted — not AI-modified
1 . A method for making a transgenomic mitochondrion incorporating an exogenous mitochondrial genome comprising the steps of;
 a) isolating a mitochondrial genome from a eukaryotic cell to yield an exogenous mitochondrial genome;   b) modifying said isolated exogenous mitochondrial genome by insertion of one or more selectable markers, screening markers, replication sequences, or combinations thereof;   c) introducing said modified isolated exogenous mitochondrial genome into a host mitochondrion from a second eukaryotic cell;   d) removing said one or more selectable markers, replication sequences, or combinations thereof, from said modified isolated exogenous mitochondrial genome within said host mitochondrion; and   e) isolating said transgenomic mitochondrion from said second eukaryotic cell.   
     
     
         2 . The method of  claim 1 , wherein said host mitochondrion from said second eukaryotic cell is a yeast mitochondrion. 
     
     
         3 . The method of  claim 2 , wherein said yeast mitochondrion is substantially free of endogenous mitochondrial DNA. 
     
     
         4 . The method of  claim 1 , wherein said exogenous mitochondrial genome is an isolated animal mitochondrial genome. 
     
     
         5 . The method of  claim 4 , wherein said isolated animal mitochondrial genome is modified prior to introduction into said isolated yeast mitochondrion. 
     
     
         6 . The method of  claim 5 , wherein said isolated animal mitochondrial genome is modified by one or more selectable markers, screening markers, replication sequences, or combinations thereof, said selectable markers, screening markers, and replication sequences having a prokaryotic origin. 
     
     
         7 . The method of  claim 5 , wherein said isolated animal mitochondrial genome is modified by one or more selectable markers, screening markers, replication sequences, or combinations thereof, said selectable markers, screening markers, and replication sequences having a eukaryotic origin. 
     
     
         8 . The method of  claim 5 , wherein said isolated animal mitochondrial genome is modified by one or more selectable markers, screening markers, replication sequences, or combinations thereof, said selectable markers, screening markers, and replication sequences having a synthetic origin. 
     
     
         9 . The method of  claim 5 , wherein said isolated animal mitochondrial genome constitutes at least 80% of naturally occurring said isolated animal mitochondrial genome. 
     
     
         10 . The method of  claim 9 , wherein said isolated animal mitochondrial genome is introduced into said host yeast mitochondrion. 
     
     
         11 . The method of  claim 10 , wherein said introduction of said isolated animal mitochondrial genome into said host yeast mitochondrion is by particle bombardment. 
     
     
         12 . A transgenomic mitochondrion comprising:
 a mitochondrion having an outer membrane and an inner membrane;   a matrix located inside said inner membrane; and   an exogenous mitochondrial genome that is incorporated into and stably replicating within said matrix of said mitochondrion.   
     
     
         13 . The transgenomic mitochondrion of  claim 12 , wherein said mitochondrion is an isolated yeast mitochondrion comprising an exogenous mitochondrial genome. 
     
     
         14 . The transgenomic mitochondrion of  claim 12 , wherein said exogenous mitochondrial genome comprises an exogenous animal mitochondrial genome. 
     
     
         15 . The transgenomic mitochondrion of  claim 14 , wherein said animal mitochondrial genome is selected from the group consisting of avian, mammalian, murine, bovine, porcine, or human mitochondrial genomes. 
     
     
         16 . The transgenomic mitochondrion of  claim 13 , wherein said mitochondrion is a yeast mitochondrion comprising an animal mitochondrial genome. 
     
     
         17 . The transgenomic mitochondrion of  claim 15 , wherein said animal mitochondrial genome is a mouse mitochondrial genome. 
     
     
         18 . The transgenomic mitochondrion of  claim 15 , wherein said animal mitochondrial genome is a human mitochondrial genome. 
     
     
         19 . The transgenomic mitochondrion of  claim 13 , wherein said isolated yeast mitochondrion is substantially free of endogenous yeast mitochondrial DNA. 
     
     
         20 . A transmitochondrial cell comprising:
 a eukaryotic cell having a plasma membrane, cytoplasm, a nucleus; and   a transgenomic mitochondrion incorporated into said cytoplasm of said eukaryotic cell, said transgenomic mitochondrion having a modified exogenous mitochondrial genome within said mitochondrion.   
     
     
         21 . The transmitochondrial cell of  claim 20 , wherein said transgenomic mitochondrion is not endogenous to said eukaryotic cell. 
     
     
         22 . The transmitochondrial cell of  claim 20 , wherein said modified exogenous mitochondrial genome is stably replicating within said transgenomic mitochondrion within said eukaryotic cell. 
     
     
         23 . The transmitochondrial cell of  claim 21 , wherein said transgenomic mitochondrion is a yeast mitochondrion. 
     
     
         24 . The transmitochondrial cell of  claim 22 , wherein said modified exogenous mitochondrial genome is an animal genome.

Join the waitlist — get patent alerts

Track US2013203160A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.